Author

Bahar Saberzadeh Ardestani

Observed names: Ardestani Bahar Saberzadeh, B. Saberzadeh Ardestani

Institution: Mayo Clinic

Observed institution: Mayo Clinic

OpenAlex ID: A5088071269

Efficacy of pembrolizumab as first-line therapy in patients with mismatch repair–deficient metastatic colorectal cancer in relation to the metastatic site.

2023 · Bahar Saberzadeh Ardestani, Jeremy Clifton Jones, et al. · Journal of Clinical Oncology · 3

569P Artificial intelligence for detection of mismatch repair deficiency in colon carcinomas (alliance)

2023 · F.A. Sinicrope, G. Nelson, et al. · Annals of Oncology · 2

Metastatic site and clinical outcome of patients with deficient mismatch repair metastatic colorectal cancer treated with an immune checkpoint inhibitor in the first-line setting.

2024 · Bahar Saberzadeh Ardestani, Jeremy Clifton Jones, et al. · Journal of Clinical Oncology · 1

Pathological analysis of tumor microenvironmental features using deep learning to predict survival of colon carcinomas.

2023 · Frank A. Sinicrope, Garth D. Nelson, et al. · Journal of Clinical Oncology · 1

Spatially resolved multi-region proteomics for prediction of clinical outcome in deficient mismatch repair metastatic colorectal cancer treated with PD-1 blockade.

2024 · Bahar Saberzadeh Ardestani, Zhenglong Liu, et al. · Journal of Clinical Oncology

92 Use of Deep Learning to Evaluate Tumor Morphological Features for Prediction of Colon Cancer Recurrence

2024 · Bahar Saberzadeh Ardestani, Garth D. Nelson, et al. · Gastroenterology

Comparative gene expression and pathway analysis of neuroendocrine neoplasms in relation to clinical outcomes and tumor location

2023 · Bahar Laderian, Ardestani Bahar Saberzadeh, et al. · Endocrine Abstracts

1190P Comparative gene expression and mutational profiling of neuroendocrine neoplasm in relation to clinical outcome

2023 · B. Saberzadeh Ardestani, A. Ford, et al. · Annals of Oncology

Comparison of synchronous neoplasms at colonoscopic diagnosis of early-onset versus average-onset colorectal cancer.

2023 · Oluwadunni Eunice Emiloju, Bahar Saberzadeh Ardestani, et al. · Journal of Clinical Oncology

Artificial intelligence–derived immune phenotypes for prediction of prognosis in patients with stage III colon cancer (NCCTG N0147; Alliance).

2023 · Bahar Saberzadeh Ardestani, Garth D. Nelson, et al. · Journal of Clinical Oncology

Sa1183 SYNCHRONOUS NEOPLASIA AT COLONOSCOPIC DIAGNOSIS OF EARLY-ONSET VERSUS LATER-ONSET COLORECTAL CANCER

2023 · Bahar Saberzadeh Ardestani, Oluwadunni E. Emiloju, et al. · Gastroenterology

Comparison of precursor neoplasms at colonoscopic diagnosis of early-onset and later-onset colon cancer.

2023 · Oluwadunni Eunice Emiloju, Bahar Saberzadeh Ardestani, et al. · Journal of Clinical Oncology

Effect of primary tumor sidedness on the association of tumor-infiltrating lymphocytes with survival of patients with stage III colon cancer (NCCTG N0147) [alliance].

2022 · Bahar Saberzadeh Ardestani, Nathan R. Foster, et al. · Journal of Clinical Oncology

Works count: 13

Citation count: 7

H-index: 2

I10-index: